Valuation: CellaVision AB

Market Cap 3.53B 369M 321M 299M 275M 518M 35.17B 527M 1.38B 17.54B 1.39B 1.36B 57.85B P/E 2026 *
25.4x
P/E 2027 * 20.2x
Enterprise Value 3.34B 349M 304M 283M 260M 491M 33.3B 499M 1.31B 16.61B 1.31B 1.28B 54.77B EV / Sales 2026 *
4.31x
EV / Sales 2027 * 3.8x
Free-Float
83.08%
Yield 2026 *
1.86%
Yield 2027 * 2.12%
1 day+3.78%
3 months+3.78%
6 months-19.08%
Current year-16.80%
Current year 13.49
Extreme 13.49
17.3
1 year 13.49
Extreme 13.49
17.3
3 years 13.49
Extreme 13.49
25.9
5 years 13.49
Extreme 13.49
34.75
10 years 13.49
Extreme 13.49
41.48
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+3.78%-.--% - - 368M
+3.30%+5.09%+23.74%-39.58% 15.7B
+4.12%+7.51%+8.10%+116.74% 1.77B
+5.61%+5.23%-22.36%-78.66% 1.14B
-0.81%+0.30%-34.47%+21.48% 980M
+1.73%+5.26%-43.43%-52.03% 655M
-0.55%+5.65%-45.94%-52.30% 543M
+6.52%+8.56%+66.02%-47.37% 472M
+4.26%+4.08%-50.62%-46.78% 374M
+5.12%+18.09%+31.15%+33.44% 329M
Average +3.31%+5.20%-7.54%-16.12% 2.44B
Weighted average by Cap. +3.28%+4.98%+13.51%-26.15%

Financials

2026 *2027 *
Net sales 775M 81.01M 70.41M 65.74M 60.35M 114M 7.72B 116M 304M 3.85B 304M 298M 12.7B 870M 90.93M 79.03M 73.78M 67.74M 128M 8.67B 130M 341M 4.32B 342M 334M 14.26B
Net income 139M 14.53M 12.63M 11.79M 10.82M 20.41M 1.38B 20.76M 54.45M 691M 54.58M 53.37M 2.28B 174M 18.23M 15.84M 14.79M 13.58M 25.6M 1.74B 26.04M 68.29M 866M 68.46M 66.94M 2.86B
Net Debt -188M -19.6M -17.03M -15.9M -14.6M -27.53M -1.87B -28.01M -73.44M -932M -73.61M -71.98M -3.07B -222M -23.19M -20.16M -18.82M -17.28M -32.57M -2.21B -33.14M -86.9M -1.1B -87.11M -85.18M -3.64B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
148.00SEK
Average target price
175.67SEK
Spread / Average Target
+18.69%

Quarterly revenue - Rate of surprise